JP2026041845A5 - - Google Patents
Info
- Publication number
- JP2026041845A5 JP2026041845A5 JP2025210219A JP2025210219A JP2026041845A5 JP 2026041845 A5 JP2026041845 A5 JP 2026041845A5 JP 2025210219 A JP2025210219 A JP 2025210219A JP 2025210219 A JP2025210219 A JP 2025210219A JP 2026041845 A5 JP2026041845 A5 JP 2026041845A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- antibody
- antigen
- sequence described
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010972365.6 | 2020-09-16 | ||
| CN202010972365 | 2020-09-16 | ||
| CN202011624826 | 2020-12-31 | ||
| CN202011624826.7 | 2020-12-31 | ||
| PCT/CN2021/116651 WO2022057651A1 (zh) | 2020-09-16 | 2021-09-06 | 抗Nectin-4抗体、包含所述抗体的缀合物及其应用 |
| JP2023516174A JP7458686B2 (ja) | 2020-09-16 | 2021-09-06 | 抗ネクチン－４抗体、それを含むコンジュゲート、及びその適用 |
| JP2023138150A JP7649826B2 (ja) | 2020-09-16 | 2023-08-28 | 抗ネクチン－４抗体、それを含むコンジュゲート、及びその適用 |
| JP2024209392A JP7784511B2 (ja) | 2020-09-16 | 2024-12-02 | 抗ネクチン－４抗体、それを含むコンジュゲート、及びその適用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024209392A Division JP7784511B2 (ja) | 2020-09-16 | 2024-12-02 | 抗ネクチン－４抗体、それを含むコンジュゲート、及びその適用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026041845A JP2026041845A (ja) | 2026-03-10 |
| JP2026041845A5 true JP2026041845A5 (enExample) | 2026-04-21 |
Family
ID=80777562
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023516174A Active JP7458686B2 (ja) | 2020-09-16 | 2021-09-06 | 抗ネクチン－４抗体、それを含むコンジュゲート、及びその適用 |
| JP2023138151A Active JP7649827B2 (ja) | 2020-09-16 | 2023-08-28 | 抗ネクチン－４抗体、それを含むコンジュゲート、及びその適用 |
| JP2023138150A Active JP7649826B2 (ja) | 2020-09-16 | 2023-08-28 | 抗ネクチン－４抗体、それを含むコンジュゲート、及びその適用 |
| JP2024209392A Active JP7784511B2 (ja) | 2020-09-16 | 2024-12-02 | 抗ネクチン－４抗体、それを含むコンジュゲート、及びその適用 |
| JP2025210219A Pending JP2026041845A (ja) | 2020-09-16 | 2025-12-01 | 抗ネクチン－４抗体、それを含むコンジュゲート、及びその適用 |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023516174A Active JP7458686B2 (ja) | 2020-09-16 | 2021-09-06 | 抗ネクチン－４抗体、それを含むコンジュゲート、及びその適用 |
| JP2023138151A Active JP7649827B2 (ja) | 2020-09-16 | 2023-08-28 | 抗ネクチン－４抗体、それを含むコンジュゲート、及びその適用 |
| JP2023138150A Active JP7649826B2 (ja) | 2020-09-16 | 2023-08-28 | 抗ネクチン－４抗体、それを含むコンジュゲート、及びその適用 |
| JP2024209392A Active JP7784511B2 (ja) | 2020-09-16 | 2024-12-02 | 抗ネクチン－４抗体、それを含むコンジュゲート、及びその適用 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20250223352A2 (enExample) |
| EP (1) | EP4215546A4 (enExample) |
| JP (5) | JP7458686B2 (enExample) |
| KR (1) | KR20230069111A (enExample) |
| CN (2) | CN117285629A (enExample) |
| AU (1) | AU2021345721A1 (enExample) |
| BR (1) | BR112022026611A2 (enExample) |
| CA (1) | CA3194765A1 (enExample) |
| CL (2) | CL2023000741A1 (enExample) |
| CO (1) | CO2023003210A2 (enExample) |
| CR (1) | CR20230128A (enExample) |
| DO (1) | DOP2023000054A (enExample) |
| EC (1) | ECSP23019525A (enExample) |
| GE (2) | GEAP202516662A (enExample) |
| IL (1) | IL301387A (enExample) |
| JO (1) | JOP20230058A1 (enExample) |
| MX (1) | MX2023002805A (enExample) |
| PE (1) | PE20230844A1 (enExample) |
| WO (1) | WO2022057651A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250205353A1 (en) | 2022-03-23 | 2025-06-26 | Synaffix B.V. | Antibody-conjugates for targeting of tumours expressing nectin-4 |
| WO2024012541A1 (zh) * | 2022-07-14 | 2024-01-18 | 百奥泰生物制药股份有限公司 | 抗Nectin-4抗体药物偶联物及应用 |
| EP4310101A1 (en) * | 2022-07-22 | 2024-01-24 | Emergence Therapeutics AG | Novel anti-nectin-4 antibodies and antibody-drug conjugates |
| CN117567620A (zh) * | 2023-09-28 | 2024-02-20 | 深圳市汉科生物工程有限公司 | 一种Nectin-4单克隆抗体及其CAR-NK细胞 |
| WO2025162493A1 (zh) * | 2024-01-29 | 2025-08-07 | 甘李药业股份有限公司 | 抗Nectin-4抗体、配体药物偶联物及其应用 |
| CN117986367B (zh) * | 2024-04-02 | 2024-07-16 | 上海美迪西生物医药股份有限公司 | 靶点为Nectin-4的抗体及其应用 |
| KR20250177512A (ko) * | 2024-06-14 | 2025-12-24 | 삼성바이오에피스 주식회사 | 신규한 항-넥틴-4 항체 및 이의 용도 |
| WO2025261506A1 (zh) * | 2024-06-21 | 2025-12-26 | 信达生物制药(苏州)有限公司 | 抗Nectin-4抗体以及其用途 |
| WO2026008043A1 (zh) * | 2024-07-04 | 2026-01-08 | 石药集团巨石生物制药有限公司 | 靶向Nectin-4的抗体药物缀合物和免疫检查点抑制剂联合的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| MX347954B (es) | 2010-09-29 | 2017-05-19 | Agensys Inc | Conjugados de anticuerpo farmaco (adc) que enlazan a proteinas 191p4d12. |
| EP3347048B1 (en) * | 2015-09-09 | 2020-04-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antibodies having specificity to nectin-4 and uses thereof |
| CN106729743B (zh) * | 2015-11-23 | 2021-09-21 | 四川科伦博泰生物医药股份有限公司 | 抗ErbB2抗体-药物偶联物及其组合物、制备方法和应用 |
| CN110392697A (zh) * | 2017-03-02 | 2019-10-29 | 国家医疗保健研究所 | 对nectin-4具有特异性的抗体及其用途 |
| WO2018226578A1 (en) * | 2017-06-05 | 2018-12-13 | Agensys, Inc. | Nectin-4-binding proteins and methods of use thereof |
| CN119241554A (zh) | 2017-12-15 | 2025-01-03 | 四川科伦博泰生物医药股份有限公司 | 生物活性物偶联物及其制备方法和用途 |
| KR102892725B1 (ko) * | 2018-05-09 | 2025-12-01 | 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. | 인간 넥틴4에 특이적인 항체 |
| CN110903395A (zh) * | 2018-09-14 | 2020-03-24 | 四川科伦博泰生物医药股份有限公司 | 抗体、偶联物及其制备方法和用途 |
-
2021
- 2021-09-06 EP EP21868477.7A patent/EP4215546A4/en active Pending
- 2021-09-06 BR BR112022026611A patent/BR112022026611A2/pt unknown
- 2021-09-06 KR KR1020237008623A patent/KR20230069111A/ko active Pending
- 2021-09-06 CR CR20230128A patent/CR20230128A/es unknown
- 2021-09-06 PE PE2023001160A patent/PE20230844A1/es unknown
- 2021-09-06 CA CA3194765A patent/CA3194765A1/en active Pending
- 2021-09-06 AU AU2021345721A patent/AU2021345721A1/en active Pending
- 2021-09-06 US US18/026,576 patent/US20250223352A2/en active Pending
- 2021-09-06 IL IL301387A patent/IL301387A/en unknown
- 2021-09-06 GE GEAP202516662A patent/GEAP202516662A/en unknown
- 2021-09-06 JP JP2023516174A patent/JP7458686B2/ja active Active
- 2021-09-06 CN CN202311193858.XA patent/CN117285629A/zh active Pending
- 2021-09-06 MX MX2023002805A patent/MX2023002805A/es unknown
- 2021-09-06 CN CN202180062998.6A patent/CN116234564A/zh active Pending
- 2021-09-06 GE GEAP202516220A patent/GEP20267876B/en unknown
- 2021-09-06 WO PCT/CN2021/116651 patent/WO2022057651A1/zh not_active Ceased
-
2023
- 2023-03-14 DO DO2023000054A patent/DOP2023000054A/es unknown
- 2023-03-15 CO CONC2023/0003210A patent/CO2023003210A2/es unknown
- 2023-03-15 CL CL2023000741A patent/CL2023000741A1/es unknown
- 2023-03-16 EC ECSENADI202319525A patent/ECSP23019525A/es unknown
- 2023-03-16 JO JOJO/P/2023/0058A patent/JOP20230058A1/ar unknown
- 2023-08-28 JP JP2023138151A patent/JP7649827B2/ja active Active
- 2023-08-28 JP JP2023138150A patent/JP7649826B2/ja active Active
-
2024
- 2024-12-02 JP JP2024209392A patent/JP7784511B2/ja active Active
-
2025
- 2025-06-26 CL CL2025001913A patent/CL2025001913A1/es unknown
- 2025-12-01 JP JP2025210219A patent/JP2026041845A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2026041845A5 (enExample) | ||
| JP2020510422A5 (enExample) | ||
| US20250034273A1 (en) | Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof | |
| JP2023543493A5 (enExample) | ||
| EP3915580A1 (en) | Multispecific antibody | |
| JP2024001073A5 (enExample) | ||
| KR20180054492A (ko) | CD66c에 특이적으로 결합하는 항체 및 그의 용도 | |
| JP7720989B2 (ja) | Ｅｇｆｒ及びｈｅｒ３を標的とする二重特異性四価抗体 | |
| JP2024507959A (ja) | 抗Ｓｉｇｌｅｃ１５抗体およびその使用 | |
| JP2019512210A5 (enExample) | ||
| JP2025513745A5 (enExample) | ||
| EP4069298A1 (en) | Composition of triaxial antibodies and method of making and using thereof | |
| JP2022544308A5 (enExample) | ||
| JP2025508606A5 (enExample) | ||
| JP2022502079A5 (enExample) | ||
| JP2024517760A (ja) | 抗５ｔ４抗体及びその使用 | |
| CN101233155B (zh) | 人抗表皮生长因子受体抗体 | |
| JP2023526976A (ja) | 多重特異性抗体 | |
| WO2023222135A1 (en) | A method of treating solid tumor | |
| JP2022544307A5 (enExample) | ||
| IL321677A (en) | Anti-PDL1 antibodies, multispecific antibodies, and methods of use | |
| JP2024508597A5 (enExample) | ||
| IL321672A (en) | Anti-pdl1/vegf antibodies and methods of use | |
| WO2025117871A1 (en) | Bispecific tetravalent antibody targeting her2 and her3 | |
| RU2025136924A (ru) | Антитела против клаудина 18.2 и способы их получения и применения |